ALS‐linked protein disulfide isomerase variants cause motor dysfunction. (11th February 2016)
- Record Type:
- Journal Article
- Title:
- ALS‐linked protein disulfide isomerase variants cause motor dysfunction. (11th February 2016)
- Main Title:
- ALS‐linked protein disulfide isomerase variants cause motor dysfunction
- Authors:
- Woehlbier, Ute
Colombo, Alicia
Saaranen, Mirva J
Pérez, Viviana
Ojeda, Jorge
Bustos, Fernando J
Andreu, Catherine I
Torres, Mauricio
Valenzuela, Vicente
Medinas, Danilo B
Rozas, Pablo
Vidal, Rene L
Lopez‐Gonzalez, Rodrigo
Salameh, Johnny
Fernandez‐Collemann, Sara
Muñoz, Natalia
Matus, Soledad
Armisen, Ricardo
Sagredo, Alfredo
Palma, Karina
Irrazabal, Thergiory
Almeida, Sandra
Gonzalez‐Perez, Paloma
Campero, Mario
Gao, Fen‐Biao
Henny, Pablo
van Zundert, Brigitte
Ruddock, Lloyd W
Concha, Miguel L
Henriquez, Juan P
Brown, Robert H
Hetz, Claudio
… (more) - Abstract:
- Abstract: Disturbance of endoplasmic reticulum (ER) proteostasis is a common feature of amyotrophic lateral sclerosis (ALS). Protein disulfide isomerases (PDIs) are ER foldases identified as possible ALS biomarkers, as well as neuroprotective factors. However, no functional studies have addressed their impact on the disease process. Here, we functionally characterized four ALS‐linked mutations recently identified in two major PDI genes, PDIA1 and PDIA3/ERp57. Phenotypic screening in zebrafish revealed that the expression of these PDI variants induce motor defects associated with a disruption of motoneuron connectivity. Similarly, the expression of mutant PDIs impaired dendritic outgrowth in motoneuron cell culture models. Cellular and biochemical studies identified distinct molecular defects underlying the pathogenicity of these PDI mutants. Finally, targeting ERp57 in the nervous system led to severe motor dysfunction in mice associated with a loss of neuromuscular synapses. This study identifies ER proteostasis imbalance as a risk factor for ALS, driving initial stages of the disease. Synopsis: The degeneration of motoneurons in ALS is associated with a chronic endoplasmic reticulum (ER) stress response. Here we report the consequences of mutations of two major ER foldases in ALS known as PDIA1 and ERp57. Expression of these ALS‐linked mutants trigger some cardinal features of ALS, including the disruption of motoneuron connectivity and function, highlighting ERAbstract: Disturbance of endoplasmic reticulum (ER) proteostasis is a common feature of amyotrophic lateral sclerosis (ALS). Protein disulfide isomerases (PDIs) are ER foldases identified as possible ALS biomarkers, as well as neuroprotective factors. However, no functional studies have addressed their impact on the disease process. Here, we functionally characterized four ALS‐linked mutations recently identified in two major PDI genes, PDIA1 and PDIA3/ERp57. Phenotypic screening in zebrafish revealed that the expression of these PDI variants induce motor defects associated with a disruption of motoneuron connectivity. Similarly, the expression of mutant PDIs impaired dendritic outgrowth in motoneuron cell culture models. Cellular and biochemical studies identified distinct molecular defects underlying the pathogenicity of these PDI mutants. Finally, targeting ERp57 in the nervous system led to severe motor dysfunction in mice associated with a loss of neuromuscular synapses. This study identifies ER proteostasis imbalance as a risk factor for ALS, driving initial stages of the disease. Synopsis: The degeneration of motoneurons in ALS is associated with a chronic endoplasmic reticulum (ER) stress response. Here we report the consequences of mutations of two major ER foldases in ALS known as PDIA1 and ERp57. Expression of these ALS‐linked mutants trigger some cardinal features of ALS, including the disruption of motoneuron connectivity and function, highlighting ER proteostasis imbalance as a driver of the initial stages of the disease. ALS‐linked mutations in PDIA1 and ERp57 adversely affect PDI structure and function. PDI mutants cause abnormal motoneuron morphology and functionality. Targeting of ERp57 in the CNS results in premature death and impaired motor control. ERp57 deficiency causes alterations of neuromuscular junctions. Abstract : Disease phenotypes associated with expression of mutant PDIA1 and ERp57 show how impaired ER proteostasis can drive initial stages of amyotrophic lateral sclerosis pathology. … (more)
- Is Part Of:
- EMBO journal. Volume 35:Number 8(2016)
- Journal:
- EMBO journal
- Issue:
- Volume 35:Number 8(2016)
- Issue Display:
- Volume 35, Issue 8 (2016)
- Year:
- 2016
- Volume:
- 35
- Issue:
- 8
- Issue Sort Value:
- 2016-0035-0008-0000
- Page Start:
- 845
- Page End:
- 865
- Publication Date:
- 2016-02-11
- Subjects:
- amyotrophic lateral sclerosis -- ERp57 -- PDIA1 -- protein disulfide isomerase
Molecular biology -- Periodicals
572.805 - Journal URLs:
- http://onlinelibrary.wiley.com/ ↗
- DOI:
- 10.15252/embj.201592224 ↗
- Languages:
- English
- ISSNs:
- 0261-4189
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3733.085000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 1378.xml